Skip to main content

Advertisement

SpringerLink
Log in

Pertuzumab to bolster Roche/Genentech's breast cancer franchise?

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Dublin

    Cormac Sheridan

Authors
  1. Cormac Sheridan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheridan, C. Pertuzumab to bolster Roche/Genentech's breast cancer franchise?. Nat Biotechnol 29, 856–857 (2011). https://doi.org/10.1038/nbt1011-856b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1011-856b

  • Springer Nature America, Inc.

Search

Navigation